Astral Systems raises $27.6M Series A (United Kingdom, Jun 2026)

$27.6M
€26 million Series A
Generated social card
Astral Systems social card
Headline

Bristol's Astral Systems secures €26 million Series A to support medical isotope commercialisation - EU-Startups

About

Astral Systems is a British DeepTech firm that specializes in pioneering multi-state fusion technology. The company aims to produce critical medical isotopes for diagnosis, treatment, and research, addressing the fragile supply chain and potential global shortages in this area.

Article summary

Bristol's Astral Systems secures €26 million Series A to support medical isotope commercialisation  EU-Startups

Founder
Talmon Firestone
Talmon Firestone
CEO and co-founder
Investors · 6
4 hidden
Mercia VenturesLead
FUND
Tees River
FUND
Related rounds
Jun 23, 2026TRIMTECH Therapeutics$44.1MSeedUnited Kingdom
Jun 22, 2026Isometric$36.4MUnited Kingdom
Jun 18, 2026NHS AI agent startup$12KUnited Kingdom
Jun 18, 2026Space Forge$12KGrantUnited Kingdom